Innoveren Scientific Inc.
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc. (IVRN) - Total Liabilities
Latest total liabilities as of September 2023: $11.68 Million USD
Based on the latest financial reports, Innoveren Scientific Inc. (IVRN) has total liabilities worth $11.68 Million USD as of September 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Innoveren Scientific Inc. - Total Liabilities Trend (2019–2022)
This chart illustrates how Innoveren Scientific Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Innoveren Scientific Inc. Competitors by Total Liabilities
The table below lists competitors of Innoveren Scientific Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
KWG PROPERTY (KOU.SG)
STU:KOU
|
Germany | €149.39 Billion |
|
PT Medela Potentia Tbk
JK:MDLA
|
Indonesia | Rp3.21 Trillion |
|
DFNN Inc
PSE:DFNN
|
Philippines | ₱1.81 Billion |
|
EASTFIELD RES
BE:35E
|
Germany | €320.85K |
|
W.A.G payment solutions plc
LSE:EWG
|
UK | GBX854.47 Million |
|
CVR Medical Corp
STU:B3BN
|
Germany | €4.82 Million |
|
Brite-Strike Tactical Illumination Products Inc
PINK:BSTK
|
USA | $177.48K |
Liability Composition Analysis (2019–2022)
This chart breaks down Innoveren Scientific Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 14.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Innoveren Scientific Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Innoveren Scientific Inc. (2019–2022)
The table below shows the annual total liabilities of Innoveren Scientific Inc. from 2019 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $9.49 Million | +90.52% |
| 2021-12-31 | $4.98 Million | +53.25% |
| 2020-12-31 | $3.25 Million | -51.25% |
| 2019-12-31 | $6.67 Million | -- |